Ho Yu-Hsuan, Shah Pramod, Chen Yi-Wen, Chen Chien-Sheng
From the ‡Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan; §Department of Biomedical Science and Engineering, National Central University, Jhongli 32001, Taiwan.
From the ‡Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan; §Department of Biomedical Science and Engineering, National Central University, Jhongli 32001, Taiwan
Mol Cell Proteomics. 2016 Jun;15(6):1837-47. doi: 10.1074/mcp.M115.054999. Epub 2016 Feb 22.
Antimicrobial peptides (AMPs) act either through membrane lysis or by attacking intracellular targets. Intracellular targeting AMPs are a resource for antimicrobial agent development. Several AMPs have been identified as intracellular targeting peptides; however, the intracellular targets of many of these peptides remain unknown. In the present study, we used an Escherichia coli proteome microarray to systematically identify the protein targets of three intracellular targeting AMPs: bactenecin 7 (Bac7), a hybrid of pleurocidin and dermaseptin (P-Der), and proline-arginine-rich peptide (PR-39). In addition, we also included the data of lactoferricin B (LfcinB) from our previous study for a more comprehensive analysis. We analyzed the unique protein hits of each AMP in the Kyoto Encyclopedia of Genes and Genomes. The results indicated that Bac7 targets purine metabolism and histidine kinase, LfcinB attacks the transcription-related activities and several cellular carbohydrate biosynthetic processes, P-Der affects several catabolic processes of small molecules, and PR-39 preferentially recognizes proteins involved in RNA- and folate-metabolism-related cellular processes. Moreover, both Bac7 and LfcinB target purine metabolism, whereas LfcinB and PR-39 target lipopolysaccharide biosynthesis. This suggested that LfcinB and Bac7 as well as LfcinB and PR-39 have a synergistic effect on antimicrobial activity, which was validated through antimicrobial assays. Furthermore, common hits of all four AMPs indicated that all of them target arginine decarboxylase, which is a crucial enzyme for Escherichia coli survival in extremely acidic environments. Thus, these AMPs may display greater inhibition to bacterial growth in extremely acidic environments. We have also confirmed this finding in bacterial growth inhibition assays. In conclusion, this comprehensive identification and systematic analysis of intracellular targeting AMPs reveals crucial insights into the intracellular mechanisms of the action of AMPs.
抗菌肽(AMPs)通过膜裂解或攻击细胞内靶点发挥作用。细胞内靶向抗菌肽是抗菌剂开发的一个资源。已经鉴定出几种抗菌肽为细胞内靶向肽;然而,其中许多肽的细胞内靶点仍然未知。在本研究中,我们使用大肠杆菌蛋白质组芯片系统地鉴定了三种细胞内靶向抗菌肽的蛋白质靶点:杆菌肽7(Bac7)、杀鲑气单胞菌溶血素和皮肤抗菌肽的杂合体(P-Der)以及富含脯氨酸-精氨酸的肽(PR-39)。此外,我们还纳入了我们之前研究中乳铁蛋白B(LfcinB)的数据以进行更全面的分析。我们在京都基因与基因组百科全书中分析了每种抗菌肽的独特蛋白质命中情况。结果表明,Bac7靶向嘌呤代谢和组氨酸激酶,LfcinB攻击转录相关活动和几个细胞碳水化合物生物合成过程,P-Der影响几个小分子的分解代谢过程,PR-39优先识别参与RNA和叶酸代谢相关细胞过程的蛋白质。此外,Bac7和LfcinB都靶向嘌呤代谢,而LfcinB和PR-39靶向脂多糖生物合成。这表明LfcinB和Bac7以及LfcinB和PR-39在抗菌活性上具有协同作用,这通过抗菌试验得到了验证。此外,所有四种抗菌肽的共同命中表明它们都靶向精氨酸脱羧酶,这是大肠杆菌在极端酸性环境中生存的关键酶。因此,这些抗菌肽在极端酸性环境中可能对细菌生长表现出更大的抑制作用。我们也在细菌生长抑制试验中证实了这一发现。总之,对细胞内靶向抗菌肽的这种全面鉴定和系统分析揭示了抗菌肽细胞内作用机制的关键见解。